Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Biogeneric Debate Likely For 2007 Congressional Session

Dec. 26, 2006

By Aaron Lorenzo

Industry Mulling Movement Toward Price Transparency

Dec. 22, 2006

By Aaron Lorenzo

Industry Mulling Movement Toward Price Transparency

Dec. 22, 2006

By Aaron Lorenzo

Orexigen Files IPO To Fund Its Obesity-Fighting Drugs

Dec. 21, 2006

By Aaron Lorenzo

HHS Ends VaxGen's $877.5M Contract On Anthrax Vaccine

Dec. 21, 2006

By Aaron Lorenzo

HHS Ends VaxGen's $877.5M Contract On Anthrax Vaccine

Dec. 21, 2006

By Aaron Lorenzo

Orexigen Files IPO To Fund Its Obesity-Fighting Drugs

Dec. 21, 2006

By Aaron Lorenzo

Orphan Pressing Ahead With Lucassin NDA For Type I HRS

Dec. 20, 2006

By Aaron Lorenzo

Orphan Pressing Ahead With Lucassin NDA For Type I HRS

Dec. 20, 2006

By Aaron Lorenzo

FDA Gives Nod To BioSante's Estrogen Drug In Hot Flashes

Dec. 19, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...